Retraction: Alteration of p53-binding protein 1 expression as a risk factor for local recurrence in patients undergoing resection for extrahepatic cholangiocarcinoma (International Journal of Oncology (2011) 38 (1227-1236) DOI: 10.3892/ijo.2011.959);Alteration of p53-binding protein 1 expression as a risk factor for local recurrence in patients undergoing resection for extrahepatic cholangiocarcinoma

International Journal of Oncology

Volumn 38, Issue 5, 2011, Pages 1227-1236

  Wakai, Toshifumi ^a   Shirai, Yoshio ^a   Sakata, Jun ^a   Korita, Pavel V ^a   Matsuda, Yasunobu ^a   Takamura, Masaaki ^a   Ohashi, Riuko ^a   Nagahashi, Masayuki ^a   Ajioka, Yoichi ^a   Hatakeyama, Katsuyoshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Cholangiocarcinoma; Extrahepatic bile duct carcinoma; Immunofluorescence; p53 binding protein 1; Prognosis

Indexed keywords

BINDING PROTEIN; KI 67 ANTIGEN; P53 BINDING PROTEIN 1; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT SURGERY; CANCER INVASION; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CARCINOMA IN SITU; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DUCTAL RESECTION MARGIN; ENZYME INACTIVATION; EXTRAHEPATIC CHOLANGIOCARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIVER RESECTION; LYMPHADENECTOMY; MALE; NICK END LABELING; PANCREATICODUODENECTOMY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETROSPECTIVE STUDY; SURGICAL APPROACH; SURGICAL PATIENT; SURVIVAL RATE;

EID: 79955005723     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/IJO.2021.5258     Document Type: Erratum

References (36)

1. Bonner WM, Redon CE, Dickey JS, et al: γH2AX and cancer. Nat Rev Cancer 8: 957-967, 2008.
2. Difilippantonio S, Gapud E, Wong N, et al: 53BP1 facilitates long-range DNA end-joining during V(D)J recombination. Nature 456: 529-533, 2008. (Pubitemid 50304846)
3. Gorgoulis VG, Vassiliou LV, Karakaidos P, et al: Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434: 907-913, 2005. (Pubitemid 40559004)
4. Stavnezer J, Guikema JE and Schrader CE: Mechanism and regulation of class switch recombination. Annu Rev Immunol 26: 261-292, 2008. (Pubitemid 351600377)
5. Nakashima M, Suzuki K, Meirmanov S, et al: Foci formation of P53-binding protein 1 in thyroid tumors: activation of genomic instability during thyroid carcinogenesis. Int J Cancer 122: 1082-1088, 2008. (Pubitemid 351214006)
6. Naruke Y, Nakashima M, Suzuki K, et al: Alteration of p53-binding protein 1 expression during skin carcinogenesis: association with genomic instability. Cancer Sci 99: 946-951, 2008. (Pubitemid 351997596)
7. Wakai T, Shirai Y, Moroda T, Yokoyama N and Hatakeyama K: Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer 103: 1210-1216, 2005. (Pubitemid 40328092)
8. Sasaki R, Takeda Y, Funato O, et al: Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma. World J Surg 1: 1788-1796, 2007. (Pubitemid 47283184)
9. Ojima H, Kanai Y, Iwasaki M, et al: Intraductal carcinoma component as a favorable prognostic factor in biliary tract carcinoma. Cancer Sci 100: 62-70, 2009.
10. Igami T, Nagino M, Oda K, et al: Clinicopathologic study of cholangiocarcinoma with superficial spread. Ann Surg 249: 296-302, 2009.
11. Nakanishi Y, Kondo S, Zen Y, et al: Impact of residual in situ carcinoma on postoperative survival in 125 patients with extrahepatic bile duct carcinoma. J Hepatobiliary Pancreat Sci 17: 166-173, 2010.
12. Shingu Y, Ebata T, Nishio H, Igami T, Shimoyama Y and Nagino M: Clinical value of additional resection of a margin-positive proximal bile duct in hilar cholangiocarcinoma. Surgery 147: 49-56, 2010.
13. Higuchi R, Ota T, Araida T, Kobayashi M, Furukawa T and Yamamoto M: Prognostic relevance of ductal margins in operative resection of bile duct cancer. Surgery 148: 7-14, 2010.
14. Nakanishi Y, Kondo S, Hirano S, et al: Recurrence of mucosal carcinoma of the bile duct, with superficial flat spread, 12 years after operation. J Hepatobiliary Pancreat Surg 13: 355-358, 2006. (Pubitemid 44111347)
15. Sasaki T, Kondo S, Ambo Y, et al: Local recurrence at hepaticojejunostomy 9 years after resection of bile duct cancer with superficial flat spread. J Hepatobiliary Pancreat Surg 13: 458-462, 2006. (Pubitemid 44480251)
16. Nakanishi Y, Zen Y, Kawakami H, et al: Extrahepatic bile duct carcinoma with extensive intraepithelial spread: a clinicopathological study of 21 cases. Mod Pathol 21: 807-816, 2008. (Pubitemid 351896664)
17. Greene FL, Page DL, Fleming ID, et al: American Joint Committee on Cancer Staging Manual. 6th edition, Springer-Verlag, New York, pp145-150, 2002.
18. Shirai Y, Yoshida K, Tsukada K and Muto T: Inapparent carcinoma of the gallbladder. An appraisal of a radical second operation after simple cholecystectomy. Ann Surg 215: 326-331, 1992.
19. Shirai Y, Yoshida K, Tsukada K, Ohtani T and Muto T: Identification of the regional lymphatic system of the gallbladder by vital staining. Br J Surg 79: 659-662, 1992.
20. Shirai Y, Ohtani T, Tsukada K and Hatakeyama K: Patterns of lymphatic spread of carcinoma of the ampulla of Vater. Br J Surg 84: 1012-1016, 1997. (Pubitemid 27310882)
21. Bismuth H, Nakache R and Diamond T: Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 215: 31-38, 1992.
22. Bismuth H and Corlette MB: Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 140: 170-178, 1975.
23. Albores-Saavedra J, Henson DE and Klimstra DS: Tumors of the gallbladder, extrahepatic bile ducts, and ampulla of Vater. 3rd edition, Armed Forces Institute of Pathology, Washington, DC, pp191-215, 2000.
24. Albores-Saavedra J, Henson DE and Sobin LH: Histological typing of tumours of the gallbladder and extrahepatic bile ducts. In: World Health Organization. International Histological Classification of Tumours. Springer-Verlag, Berlin, 1991.
25. Oohashi Y, Watanabe H, Ajioka Y and Hatakeyama K: p53 immunostaining distinguishes malignant from benign lesions of the gall-bladder. Pathol Int 45: 58-65, 1995.
26. Nuciforo PG, Luise C, Capra M, Pelosi G and d'Adda di Fagagna F: Complex engagement of DNA damage response pathways in human cancer and in lung tumor progression. Carcinogenesis 28: 2082-2088, 2007. (Pubitemid 47543366)
27. Rappold I, Iwabuchi K, Date T and Chen J: Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damagesignaling pathways. J Cell Biol 153: 613-620, 2001. (Pubitemid 34280146)
28. Schultz LB, Chehab NH, Malikzay A and Halazonetis TD: p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J Cell Biol 151: 1381-1390, 2000. (Pubitemid 32047588)
29. Bartkova J, Horejsí Z, Koed K, et al: DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434: 864-870, 2005. (Pubitemid 40558993)
30. Sedelnikova OA and Bonner WM: GammaH2AX in cancer cells: a potential biomarker for cancer diagnostics, prediction and recurrence. Cell Cycle 5: 2909-2913, 2006. (Pubitemid 44953946)
31. Yu T, MacPhail SH, Banáth JP, Klokov D and Olive PL: Endogenous expression of phosphorylated histone H2AX in tumors in relation to DNA double-strand breaks and genomic instability. DNA Repair 5: 935-946, 2006. (Pubitemid 44160591)
32. Endo I, House MG, Klimstra DS, et al: Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma. Ann Surg Oncol 15: 2104-2112, 2008.
33. Albores-Saavedra J, Murakata L, Krueger JE and Henson DE: Noninvasive and minimally invasive papillary carcinomas of the extrahepatic bile ducts. Cancer 89: 508-515, 2000. (Pubitemid 30640097)
34. Jarnagin WR, Bowne W, Klimstra DS, et al: Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg 241: 703-712, 2005.
35. Nagahashi M, Shirai Y, Wakai T, et al: Depth of invasion determines the postresectional prognosis for patients with T1 extrahepatic cholangiocarcinoma. Cancer 116: 400-405, 2010.
36. Risques RA, Lai LA, Brentnall TA, et al: Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage. Gastroenterology 135: 410-418, 2008.